SOLVENTUM CORPORATION (SOLV) Operating Margin
- Operating margin · 12 months: Value 24.98%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 24.98% | Operating income / revenue. Period ending 2026-06-30. $2.08B ÷ $8.31B × 100 ≈ 24.98% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 2.08B USD | Operating Income (Loss) |
| Revenue | 8.31B USD | |
| Cost of products and services | (m) | |
| Research and development | 725.00M USD | Research and Development Expense |
| Selling, general and administration | 3.29B USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2.08B | $8.31B | (m) | $725.00M | $3.29B | 24.98% |
| 2026-03-31 | $2.11B | $8.26B | (m) | $735.00M | $3.14B | 25.54% |
| 2025-12-31 | $2.18B | $8.32B | (m) | $739.00M | $3.08B | 26.20% |
| 2025-09-30 | $2.19B | $8.40B | (m) | $763.00M | $3.10B | 26.10% |
| 2025-06-30 | $778.00M | $8.39B | (m) | $769.00M | $3.03B | 9.28% |
| 2025-03-31 | $807.00M | $8.31B | (m) | $773.00M | $2.96B | 9.71% |
| 2024-12-31 | $1.04B | $8.25B | (m) | $775.00M | $2.78B | 12.55% |
| 2024-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $1.69B | $8.20B | (m) | $758.00M | $2.24B | 20.64% |
| 2023-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $1.69B | $8.13B | (m) | $767.00M | $2.23B | 20.82% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |